Skip to content

Evolent Health, Inc.

EVH

CIK 0001628908

← back to feed
Revenue (TTM)
$1.9B
−2.3% YoY Q1 May 2026
Net Income (TTM)
−$132.01M
−1,956.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.55
−1,500.0% YoY Q1 May 2026
Gross Margin
20.3%
Q1 May 2026
Operating Margin
-0.7%
Q1 May 2026
Net Margin
-6.9%
Q1 May 2026
Free Cash Flow (TTM)
−$27.83M
Q1 May 2026
Cash
$142.03M
Q1 May 2026
Total Debt
$973.49M
Q1 May 2026
Shares Outstanding
112.48M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings